MindMed @mindmedco
MindMed is a clinical stage biopharma company developing psychedelics and other novel treatments for brain health disorders. $MNMD $MMED mindmed.co Joined September 2019-
Tweets554
-
Followers24K
-
Following257
-
Likes335
MindMed will present results from the Phase 2b study of MM120 in generalized anxiety disorder (GAD) as well as multiple presentations describing the epidemiology and growing burden of GAD at two medical conferences in May. Read more: brnw.ch/21wJatg #APA2024 #ISPORAnnual
Tune in to @MadMoneyOnCNBC this evening at 6pm ET, where our CEO, Robert Barrow, sits down with host, @jimcramer to discuss the business of MindMed. $MNMD @CNBC
MindMed will present a poster on April 9, 2024 at the 32nd @Euro_Psychiatry 2024 Congress on “Prevalence of Generalized Anxiety Disorder Among Five European Countries Before and During COVID.” For more information, read our press release here: brnw.ch/21wIBTw #EPA2024
Our CMO, Dr. Karlin, explains what the FDA's breakthrough therapy designation for MM120 in GAD could mean for the drug’s development, highlighting the positive results from our Phase 2b study demonstrating MM120’s therapeutic potential. Read more @WebMD: brnw.ch/21wIvcR
MindMed will present posters on the impact of COVID-19 on GAD at the 32nd @Euro_Psychiatry Congress taking place April 6-9, and the @ADAA_Anxiety 2024 Conference taking place April 11-14. Read press release for more: bit.ly/3VCZfjW #EPA2024 #ADAA2024
Our CMO, Dr. Daniel Karlin was featured in @CNN discussing MindMed’s FDA breakthrough therapy designation for MM120 in GAD and the positive 12-week durability data from our Phase 2b study of MM120 in GAD. Read the full article here: bit.ly/3ItKO9W $MNMD
MM120 demonstrated a significant improvement in people with GAD sustained 12 weeks after a single dose, with a 68% clinical response & 48% remission rate. Learn more here: brnw.ch/21wHHEH $MNMD
Our Phase 2b trial of MM120 in GAD patients met its key secondary endpoint, demonstrating clinically & statistically significant durability of activity observed through week 12 after a single dose with no additional therapeutic intervention. Read more: brnw.ch/21wHF1f
Today, we announced the FDA has granted breakthrough therapy designation for MM120 in GAD. We also announced positive 12-week durability data from our Phase 2b study of MM120 in GAD and are hosting a call at 8AM ET to discuss details. Read more: brnw.ch/21wHEzM $MNMD
On Wednesday, February 28, MindMed will host a conference call and webcast to discuss 2023 financial results and provide a business update. Register to attend via the link here: brnw.ch/21wHday $MNMD
Our CEO, Robert Barrow, participated in the @reaganudall Foundation for the FDA’s virtual meeting on advancing #psychedelic clinical study design, exploring approaches to addressing key issues in psychedelic drug development and research. Watch here: brnw.ch/21wGY5i
Members of our management team will present a corporate overview at the 34th Annual Oppenheimer Healthcare Life Sciences Conference on February 13, 2024, at 10am EST. Register here: brnw.ch/21wGKTb $MNMD
Our CMO, Dr. Daniel Karlin, discussed the topline data results from our Phase 2b study of MM-120 in GAD, anticipated clinical development milestones, and the broader #psychedelic treatment landscape with @biospace. Read the article here: brnw.ch/21wGbF5
#ICYMI we provided a business update highlighting progress and anticipated milestones for our lead clinical program, MM-120, the Phase 1 trial initiation for MM-402 in healthy subjects, and our outlook for 2024. Read our press release to learn more: brnw.ch/21wG9wx
Positive topline results from our Phase 2b trial of MM-120 in Generalized Anxiety Disorder (GAD) reveal promise for an underserved population of patients. Learn more about the potential of MM-120: businesswire.com/news/home/2023…
Generalized Anxiety Disorder (GAD) affects roughly 20M US adults – a disorder that has proved extremely difficult to treat. Our positive Phase 2b trial results mark a step forward in unlocking the therapeutic potential of MM-120. Learn more here: businesswire.com/news/home/2023…
Our Phase 2b trial for MM-120 in GAD patients met its primary endpoint with a statistically significant dose-dependent improvement in HAM-A scores 4 weeks after a single dose. We are hosting a call at 8:30am ET to discuss the data. Read more: businesswire.com/news/home/2023…
“Zooming into the future, the real opportunity is to change the trajectory of patients’ mental health progression.” @mindmedco CEO Robert Barrow joins Breakthrough Economy host @JenSaidIt to discuss how MindMed, the first psychedelic pharmaceutical company to go public, is…
MindMed CEO Rob Barrow joined @Nasdaq Breakthrough Economy with @JenSaidIt to discuss the need for innovative treatments for brain health disorders and MindMed’s approach to unlocking the therapeutic potential of psychedelics. Watch the video here: bit.ly/40I3bR6
This week, MindMed presented the poster, “Genetic Toxicity Testing of MM-120 (Lysergide D-Tartrate) Demonstrates No Evidence of Mutagenicity” at the @ACToxicology Annual Meeting in Orlando, FL. Learn more about our MM-120 program here: bit.ly/3LWg84h #ACTOX2023
Dennis McKenna @DennisMcKenna4
88K Followers 202 Following Founder: @McKennaAcademy. The reedition of Brotherhood of the Screaming Abyss: My Life with Terence McKenna is now available!
Microdose Psychedelic.. @MicrodoseHQ
95K Followers 1K Following Shifting the world's perception of psychedelic medicine. News ⤵️ Producer of @WonderlandConf in Miami 🌴
Robin Carhart-Harris @RCarhartHarris
60K Followers 3K Following Ralph Metzner Distinguished Professor of Neurology & Psychiatry, UCSF. Psychedelic neuroscientist and psychologist.
Psychedelic Alpha @Psyched_Alpha
20K Followers 77 Following Empowering a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact in psychedelic medicine and beyond.
Psychedelic Finance @Psych_Fin
22K Followers 156 Following Helping investors discover, understand, and stay up-to-date on opportunities within the Psychedelic industry. Inquiries: [email protected]
Taylor Sterling (Arch.. @FatherMcKennaa
31K Followers 802 Following bringing fire to the people // psychedelic history, culture, & harm reduction
Beckley Foundation | .. @BeckleyResearch
59K Followers 3K Following Advancing #research into #psychedelics such as #LSD, #Psilocybin, and #DMT led by Amanda Feilding. Expanding our impact by accepting crypto https://t.co/zbztX4urA7
Dr. Rick Barnett, Psy.. @drrickbarnett
15K Followers 3K Following Licensed Psychologist #Addiction #MentalHealth - Fun, friendly, co-founder Psychedelic Society of Vermont, + CARTER, Inc. https://t.co/pWT4llpKBo
Alex Grey @alexgreycosm
110K Followers 1K Following I am a psychedelic visionary artist, co-founder with my wife Allyson, of the Chapel of Sacred Mirrors, CoSM.
Julie Holland, MD @BellevueDoc
13K Followers 2K Following psychiatrist, author, wife/mom, musician, MDMA & cannabis researcher, harm reductionist, medical advisor to MAPS ++, GOOD CHEMISTRY: The Science of Connection.
Psychedelics Today @PsydelicsToday
39K Followers 955 Following Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy.
Dr Peter Sjöstedt-Hu.. @PeterSjostedtH
20K Followers 3K Following Philosopher of Mind and Metaphysics (Whitehead – Nietzsche – Spinoza – Psilocybin)｜Lecturer (Uni of Exeter)｜Co-director of BC｜TEDx Talk: https://t.co/TEE6id7NeY
Michael Pollan @michaelpollan
562K Followers 805 Following Author of This is Your Mind on Plants; How to Change Your Mind; Cooked; In Defense of Food; The Omnivore’s Dilemma; The Botany of Desire and Second Nature.
Emma Beckerle @emmabeckerle
3K Followers 693 Following former corporate climber turned cannabis consultant turned mental health / plant medicine advocate ➡️ stream of consciousness: I tweet about what I am into.
PSYCSpotlight @PSYC_Spot
3K Followers 866 Following The leading voice for news on the psychedelics industry covering breakthrough discoveries, investor news & pop culture. OTC: $PSYC
CybinInc @CybinInc
9K Followers 214 Following Changing Minds to Revolutionize Mental Healthcare $CYBN
Rachel Yehuda @RachelYehuda
6K Followers 828 Following scientist, author, interested in: PTSD, psychedelic-assisted psychotherapy, intergenerational trauma, epigenetics, molecular neuroscience
MJ Stock Trader @stock_mj
19K Followers 1K Following Cannabis retail investor advocate. You can support my work here: https://t.co/xFbJh2ZmBl #CannabisCommunity
Numinus @NuminusHealth
8K Followers 99 Following Connect. Heal. Thrive. Combining the latest advances in psychedelic medicine with evidence-based care and a holistic, integrated approach to healing.
Jennbugxoxo @JennbugJenn
0 Followers 26 Following ⏳Life flies by quickly. Live w/o rushing or constant seeking of approval. Embrace gratitude ALWAYS, & give w/o expecting anything back.💚🌲💙
D 🌚🪩🖤✨ @gr8tefulwitch
178 Followers 547 Following I put the ‘D’ in Dissociate 👽🛸 CA 🌱🌞 Girl w/ 🧠 like NYU 🎓📍MA 🔜 CO. Bass brat, w*ed witch, indigo child, neuro nerd, gr8teful ♥️ occasional wordsmith ✍🏻
Caleb Gray @CGray1306
1 Followers 3 Following
Isabella Jasmine @AnkhNHorus
103 Followers 937 Following Crafting my own success story, one bold move at a time. 👩💼 Fearless in business, fueled by ambition. Let's inspire each other! 💫
⭐️ANNA⭐️SUPER.. @ALilac6
1K Followers 5K Following 🌻California Conservative🦅MAGA Trump Supporter🌻Law Order Peace🦅Traditionalist 🌻America First🦅🎨 Art Scavenger & Design Appreciator 🖼 🥁Country Music Fan🎸
Todd Crawford @toddcrawford33
281 Followers 538 Following Retired from serving this great nation 1989-2023 🇺🇸❤️ Jack of many trades🪅 #entreprenuer #psychiatryNP #ADHDspecialist Tweets are my opinion.
righteous_urker @RighteousLurker
0 Followers 20 Following
InterestedObserver @Interes63923782
505 Followers 3K Following Here to observe the hive mind that is the X-verse. A true love of learning and knowledge. Open to the universe. Mom, wife, traveler, gardener, LCSW.
Psychedelics Design @psychedelicsdsg
51 Followers 94 Following Where design meets psychedelics. Engage: Take our survey. Join our online events. Sign up for the free newsletter!
Varun Kapur @varunkapur
255 Followers 2K Following Venture Capital & Wellness - Equities & Macro - Biohacker - Mindfulness & Spirit - Fascinated by our Collective Future 🕉️ #FlowState #Health #Climate
Crazy Old Lady @crazyoldlady82
34 Followers 18 Following
Nate @natemxran
14 Followers 99 Following
J @notfncladvice
410 Followers 593 Following
Charlie @Charburger06
11 Followers 22 Following
✴ dark star ✴ @reconsidered
10K Followers 10K Following gnar pow love. dead head. tela. agnostic atheist. reason tatters - the forces tear loose from the axis. on fire aries.
Garbanso @pieceofgarbanzo
60 Followers 157 Following médica, queer, astróloga, batería, hummus con pimentón, aplatanada. (she/they)
Modern Monetary Man @MonetaryMattCFA
311 Followers 655 Following Buyside Analyst | Stocks | Options | CFA | Opinion/speculation only & not advice/solicitation May be L/S names, do your own due diligence, consider conflicts
Bayram Gamze Yıldır.. @BayramY61132470
7 Followers 63 Following
Stoic @StoicNoFear
93 Followers 52 Following
Jonathan Franc @bingjonathan05
0 Followers 17 Following
How did we get here @Howdidwegethe20
49 Followers 106 Following
Susan Bajwa @SusanBajwa45138
0 Followers 5 Following
🏳️🌈 Jim Si.. @SmashAllFascism
1K Followers 3K Following Pro-democracy, pro-labor, pro-union. Stop GOP White Nationalist Christo-fascism, GOP voter suppression, gerrymandering & anti-democracy Electoral College.
hudsonford @TravisEwebster
41 Followers 354 Following
きみ @7Av6n
39 Followers 61 Following
Joshua Atlas @Lordjahseek
574 Followers 949 Following Father, Musician, Tesla investor, future Mars settler.
Brendan Mahoney @mahoney2319
8 Followers 9 Following
michael steven noon @nooney1984
1K Followers 2K Following runner, outdoor adventurer, experience seeker, personal development enthusiast, & newly conspiracy theorist
Yifan Gao @_YifanGao
90 Followers 234 Following neuroscience PhD student @CmbnRutgers | previously @kayser_lab @TeachersCollege @CABlabUIUC @UofIllinois
MutationC @MutationC2
35 Followers 42 Following
The humble cock @CockHumble
21 Followers 265 Following
💎Mind the GAAP💎 @Mind_Da_GAAP
808 Followers 1K Following L/S. Views are my own and do not represent those of employers past or present.
Kenny @Kennydoesbio
1K Followers 618 Following On the hunt for bio plays, looking for buyside roles (DMs open) (ex-sell side)
Zen Squirrel @CarolSciurus
167 Followers 565 Following Equities trader who tries to squirrel away profits everyday while dodging cars.
Adam Cameron @AdamCam90884063
0 Followers 3 Following
Paul Manelis @LakeForestLion
131 Followers 405 Following Product of Saginaw public schools, hence the spelling and grammatical errors.
OneALPHA + KonaTEL Co.. @OneAlphaC1
2K Followers 5K Following Learn the secrets of investing. (NASDAQ: $KTEL)
venus @snake_skins
88 Followers 351 Following
Greg Warlitner @GWarlitner
38 Followers 27 Following
Steve Ellis @rsq25medic
10 Followers 14 Following
DANIEL OLIVER @OliverDani25545
4 Followers 16 Following
THE LINGUISTIC JUDO G.. @G2035048768002
25 Followers 45 Following NEWS NEWS NEWS **** Non-Legacy **** Corporate **** NEWS NEWS NEWS
Uri V @Unasty4
35 Followers 266 Following
Burak Demirci @BurakDemirciMD
1 Followers 51 Following
Dennis McKenna @DennisMcKenna4
88K Followers 202 Following Founder: @McKennaAcademy. The reedition of Brotherhood of the Screaming Abyss: My Life with Terence McKenna is now available!
Microdose Psychedelic.. @MicrodoseHQ
95K Followers 1K Following Shifting the world's perception of psychedelic medicine. News ⤵️ Producer of @WonderlandConf in Miami 🌴
Robin Carhart-Harris @RCarhartHarris
60K Followers 3K Following Ralph Metzner Distinguished Professor of Neurology & Psychiatry, UCSF. Psychedelic neuroscientist and psychologist.
Psychedelic Alpha @Psyched_Alpha
20K Followers 77 Following Empowering a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact in psychedelic medicine and beyond.
Psychedelic Finance @Psych_Fin
22K Followers 156 Following Helping investors discover, understand, and stay up-to-date on opportunities within the Psychedelic industry. Inquiries: [email protected]
Beckley Foundation | .. @BeckleyResearch
59K Followers 3K Following Advancing #research into #psychedelics such as #LSD, #Psilocybin, and #DMT led by Amanda Feilding. Expanding our impact by accepting crypto https://t.co/zbztX4urA7
MAPS @MAPS
136K Followers 99 Following Est.1986 Multidisciplinary Association for Psychedelic Studies. Promoting medical, legal & cultural progress through psychedelic & marijuana research.
Psychedelics Today @PsydelicsToday
39K Followers 955 Following Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy.
Matthew W. Johnson @Drug_Researcher
32K Followers 557 Following Psychedelic scientist @ Sheppard Pratt. Conducted seminal psychedelic research for 20 years at Hopkins. Expertise in many drugs, behavioral economics, addiction
Rick Doblin, Ph.D., o.. @RickDoblin
58K Followers 3 Following Founder and President of the Multidisciplinary Association for Psychedelic Studies (@MAPS) • Account managed by @MAPS
PSYCSpotlight @PSYC_Spot
3K Followers 866 Following The leading voice for news on the psychedelics industry covering breakthrough discoveries, investor news & pop culture. OTC: $PSYC
Johns Hopkins Psyched.. @JHPsychedelics
43K Followers 158 Following The Center for Psychedelic and Consciousness Research studies how psychedelics affect behavior, mood, cognition, brain function, & biological markers of health.
Rachel Yehuda @RachelYehuda
6K Followers 828 Following scientist, author, interested in: PTSD, psychedelic-assisted psychotherapy, intergenerational trauma, epigenetics, molecular neuroscience
Numinus @NuminusHealth
8K Followers 99 Following Connect. Heal. Thrive. Combining the latest advances in psychedelic medicine with evidence-based care and a holistic, integrated approach to healing.
Field Trip @fieldtriphealth
11K Followers 188 Following Helping people to heal, grow, & know themselves better through psychedelic wellness ❤️🩹 Browse our treatments 📲 Download our app
Ronan Levy @RonanDLevy
4K Followers 287 Following lawyer-turned-entrepreneur focussed on living a good, long life. https://t.co/qA77olMxey
Franklin King MD @KingFranklinIV
3K Followers 354 Following Psychiatrist/Instructor, Mass General Hospital/Harvard Medical School | antireductionist, subjective experience, psychedelics | my views
Josh Hardman @Josh__Hardman
3K Followers 311 Following Covering all aspects of psychedelics at @Psyched_Alpha.
Christian Angermayer @C_Angermayer
28K Followers 2K Following Enjoying life. Investing in (bio)tech. Creating companies, movies and good memories. #Longevity #Biotech #psychedelics
Mackenzie P @mpadvisorshares
588 Followers 198 Following
ECNPtweets @ECNPtweets
5K Followers 1K Following Scientific association dedicated to ensuring that advances in the understanding of brain function translate into better treatments and enhanced public health.
Benjamin A. Smith @BenjaminA_Smith
7K Followers 471 Following Lead financial writer & Capital markets professional, commentator, marketer. Occasionally tweet high conviction trade ideas.
BowTiedBiotech 🧪�.. @BowTiedBiotech
12K Followers 7K Following Tri-Weekly Biotech Updates: Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends | Current: Biotech VC
K2 HealthVentures @K2HVenture
68 Followers 23 Following K2 HealthVentures is a long-term provider of debt and equity capital to venture and growth stage companies in the life sciences and healthcare industries.
Sunstone Therapies @SunstoneHeals
273 Followers 104 Following Leading the research and delivery of psychedelic assisted therapies for those affected by cancer and complex mental health challenges and disorders.
Mady Mills @MadisonMills22
7K Followers 4K Following Anchor @yahoofinance 10 am hour. Formerly @business @nytimes. Stocks go up.
Frank Holland @FrankCNBC
11K Followers 4K Following Correspondent/ Anchor @CNBC @PittTweet Grad @BentleyU MBA @kapsi1911 Nupe. #Philly
Kostas Bartsokas @kostasbartsokas
1K Followers 1K Following Type designer and typographer, lover of good food, collector of experiences. MATD15-16. Co-Founder @foundryfive https://t.co/t6b3ZAu38t
EmpoweredPatient @KarenJagoda
617 Followers 181 Following The convergence of technology and health and wellness
Oppenheimer & Co. Inc.. @Oppenheimer
5K Followers 101 Following Oppenheimer is a leading global full-service brokerage and investment bank.
Blossom @blossomact
3K Followers 774 Following Built a massive free database & reports at https://t.co/7MIbGnNdrW | ✉️ subscribe to The Bloom for weekly updates | Tweet about psychedelic science & therapy
Edison @Edison_Inv_Res
4K Followers 1K Following Edison is a content-led IR business on a mission to build bigger, better and more engaged investors for our clients.
Torie Bosch @thekibos.. @thekibosch
5K Followers 3K Following First Opinion editor, First Opinion Podcast host @STATNews Senior ed @TheOpenNotebook Formerly @FutureTenseNow, @StateMindSlate, @Slate, @ASU, @NewAmerica
Ed Elson @edels0n
9K Followers 995 Following co-host Prof G Markets | host First Time Founders | @profgalloway’s analyst
Daniela Hernandez @danielas_bot
9K Followers 6K Following Explorer of extreme environments, from Antarctica to the brain and beyond. 🤩🇦🇶🎥👩🏻💻🦈🦖🇲🇽🤩 previously: @wsj @wired
Biotech Hangout @BiotechCH
12K Followers 451 Following Weekly discussion of biotech news w/ @daphnezohar @bradloncar @timopler @LifeSciVC, @cngarabedian, top analysts & a community of biotech insiders
Emily Jarvie @emilyjjarvie
1K Followers 837 Following Financial journalist @proactive_ca @proactive_NA 💸
Reunion Neuroscience @ReunionNeuro
839 Followers 201 Following Reunion is committed to innovating therapeutic solutions to treat mental health conditions through the development of novel psychedelic compounds. $REUN
Jefferies @Jefferies
7K Followers 44 Following Jefferies, the global investment banking firm serving clients for 60 years. Follow us for company news and economic insights.
CNS Summit @CNSSummit
2K Followers 733 Following CNS Summit - Created by life science leaders to advance clinical development, with a focus on collaboration, innovation, and technology. Shape the future!
Technology Networks @Tech_Networks
6K Followers 2K Following Internationally recognized online publication. We explore the science that matters to you. Subscribe to The Scientific Observer here: https://t.co/IC7zVmfwrE
Psychedelic Invest @psyinvest
3K Followers 359 Following Writing at https://t.co/ofQOK8co3P. We're hiring writers and analysts (DM us).
James D. Hallifax: Ps.. @Psy_Invest
2K Followers 659 Following Follow for Psychedelic News & Memes Nominated for "Reporter of the Year" for the Microdose awards. Want to collaborate? Email me at [email protected]
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Bruce Booth @LifeSciVC
50K Followers 732 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Jamie Freedman @JamieFree619
9 Followers 62 Following Mother. Scientist. ClinOps professional. Mastiff dog mom. Psychedelic medicines.
Jamie Freedman @JFree619
3 Followers 5 Following Mother, Pro-Choice, Scientist, Clinical Operations professional, Psychedelic Medicines.
Drug Discovery & Deve.. @DrugDiscoverDev
840 Followers 120 Following Drug Discovery & Development reports on cover #Drug introductions, formulations, pipeline candidates, #ClinicalTrial trends & #DrugDevelopments related to #AI
Biological Psychiatry @BiologicalPsyc1
4K Followers 819 Following Official Journal of @SOBP | Selective psychiatric neuroscience journal | neural circuitry and neuroschemistry | risk factors | therapeutic approaches
Dino Luethi @DinoLuethi
426 Followers 255 Following Bioanalyst @UniSpitalBasel, Liechti lab. Interested in #stimulants, #psychedelics, peaks & powder.
Conor Sen @conorsen
92K Followers 296 Following Columnist for @opinion. Founder of Peachtree Creek Investments. Sun Belt/monoculture enthusiast. The future is a policy choice.
Tara Bannow @TaraBannow
5K Followers 3K Following Reporter covering hospitals and health insurance for @statnews | New mama!💪🏻| Tips ➡️ [email protected]
Diamond Therapeutics @DiamondThera
283 Followers 278 Following The promise of a new and better class of mental health therapies lies within the chemistry of psychedelic compounds. Our mission is to unlock it.
BioTuesdays @BioTuesdays
807 Followers 406 Following Giving great healthcare companies and their stories as much exposure as we can. Subscribe to our newsletter. https://t.co/VE9jaNcNac
Manu Sharma @thecurioushrink
253 Followers 479 Following Psychiatrist and aspiring Physician Scientist, psychosis, language, NLP, Digital Health. Thoughts are hopefully my own.
Natasha Loder 🐋 @natashaloder
22K Followers 4K Following Stories that matter. Health Editor, The Economist 💉 Writer ✍️ Broadcaster🎤 Cartoonist 💬 Views own.
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Maxim Jacobs, CFA @MaxJacobsCFA
7K Followers 690 Following Experienced Buyside/Sellside/Biotech IR. Personal account. Nothing I post is meant to be investment or medical advice.
Not active @deactivehayley
397 Followers 444 Following
DelveInsight @delve_insight
259 Followers 2K Following #DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry
Catherine Schuster-Br.. @drcatherinesb
1K Followers 2K Following • Medical doctor • Award-winning journalist words @businessinsider @hsj • Consultant °Views mine °Instagram @drcatherinesb
Zach Haigney @zach_haigney
2K Followers 2K Following I write about the science, business, policy, and future of the psychedelic renaissance
Alex Calderon @iamacalderon
13K Followers 6K Following Husband + Father + Investor. Exploring investment opportunities in #psychedelics. GO #Canucks
Nasdaq @Nasdaq
117K Followers 7K Following Nasdaq is a global technology company that champions inclusive growth and prosperity, creating opportunity for markets and economies of all sizes.
On this episode of The Weekly: The Biden administration puts pressure on biopharma industry, renewed buzz around psychedelics following @mindmedco's news. Plus, @bluebirdbio changes its tune. #TheWeeklyPodcast #BiopharmaNews #IndustryInsights #BioSpace hubs.li/Q02dvj_K0
Daniel Karlin, MD, @mindmedco discusses how MM-120, a psychedelic, stands apart from other generalized anxiety disorder medication with a single dose administration and tested without psychotherapy. hcplive.com/view/daniel-ka…
Promising findings from @mindmedco's RCT of LSD for generalized anxiety disorder, which was conducted at 20+ sites, including here at @ClevelandClinic. ir.mindmed.co/news-events/pr…
$MNMD Mind Medicine's MM-120 shows promise in Phase 2b trial for Generalized Anxiety Disorder tinyurl.com/ysale3ba @mindmedco $MMED #MNMD #MMED
“Zooming into the future, the real opportunity is to change the trajectory of patients’ mental health progression.” @mindmedco CEO Robert Barrow joins Breakthrough Economy host @JenSaidIt to discuss how MindMed, the first psychedelic pharmaceutical company to go public, is…
Dr. Daniel Karlin, Chief Medical Officer for @mindmedco, discusses the clinical trials they're conducting with MM-120, an optimized version of LSD (more stability, etc.) being studied for its potential to treat Generalized Anxiety Disorder (GAD).
Listen here: mindandmatter.substack.com/p/psychiatry-p…
Latest episode of Mind & Matter: "Psychiatry, Psychedelic Medicine, LSD for Anxiety, MDMA for Autism, Medical Ethics, Patient Access & Mental Health" with Dr. Daniel Karlin of @mindmedco
New podcast: "Psychiatry, Psychedelic Medicine, LSD for Anxiety, MDMA for Autism, Medical Ethics, Patient Access & Mental Health" with Dr. Daniel Karlin from #psychedelics company @mindmedco. Link in reply.
@mindmedco is a clinical-stage US #biopharmaceutical company aiming to leverage #psychedelic medicines to target life-debilitating mental health conditions such as anxiety, ADHD and autism. Hear from CEO Rob Barrow in our latest video: hubs.ly/Q01Ml3hq0
A primer on psychedelics in drug development 🍄 Digging into the emerging science, competitive landscape and convoluted path to market Let's take a trip:
We update our psychedelics clinical trial tracker every quarter to figure out how cos are doing as they develop treatments through clinical trials. New to our @BusinessInsider tracker are phase II trials from @clairvoyantrx, Halucenx, and @mindmedco businessinsider.com/psychedelics-c…
@mindmedco is a clinical-stage US #biopharma aiming to leverage #psychedelic medicines to target debilitating mental health conditions such as #anxiety, #ADHD and #autism. Watch our recent video for more. hubs.ly/Q01DbMKz0
I spent the past few months trying to better understand how and why @COMPASSPathway, the first psychedelics startup to raise over a hundred million dollars from VCs and then go public on the Nasdaq, came to exist. Here's what I learned (1/5): businessinsider.com/inside-compass…
This morning we kicked off #BIOCEO23! In the 25th year, the BIO CEO & Investor Conference continues to fuel the biotechnology industry through partnering, company presentations, and educational sessions on therapeutic advancements, market outlook, and policy priorities.
Wrote about the new developments happening in depression treatments — from @axsome's new fast-acting drug to a bigger focus on biomarkers to psychedelics 🍄 businessinsider.com/new-drugs-depr…
Key takeaways from @mindmedco’s 2023 corporate update. #psychedelic #medicine #shroomstocks #research #science #clinical #doctors #MentalHealth $MNMD $MMED bit.ly/3Gwacul
How appropriate, considering it was a @jpmorgan executive who piqued the pharmaceutical industry's interest in psilocybin back in the 1950s...finally coming full circle, huh?
The MindMed ($MNMD) executive team is on-site at #JPM2023 in San Francisco, participating in events including @IAmBiotech one-on-one partnering, and looking forward to connecting with industry peers and investors in the healthcare community
$MMED $MNMD @mindmedco provides corporate update and 2023 outlook: - Company to initiate a first clinical trial of MM-402 in 2023 - Cash runway to fund current operating plan into the first half of 2025 #psychedelic #medicine prn.to/3ZqBuey
$MNMD $MMED A most welcome corporate update from @mindmedco. Things seem to be moving along smoothly. newswire.ca/news-releases/…
Trends for United States
You might like
